We are live on ! Find out more
FGP

Freestone Grove Partners Portfolio holdings

AUM $14.2B
1-Year Est. Return 24.58%
This Fund
S&P 500
This Quarter Est. Return
+0.81%
1 Year Est. Return
+24.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$14.2B
AUM Growth
+$326M
Cap. Flow
+$589M
Cap. Flow %
4.16%
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267

Sector Composition

Rank Sector Weight
1 Financials 16.98%
2 Technology 14.39%
3 Industrials 12.27%
4 Healthcare 11.72%
5 Consumer Discretionary 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMSC icon
976
American Superconductor
AMSC
$1.67B
-46,128
Closed -$1.33M
ANET icon
977
Arista Networks
ANET
$220B
-393,164
Closed -$51.5M
APH icon
978
Amphenol
APH
$185B
-147,085
Closed -$19.9M
APLS
979
DELISTED
Apellis Pharmaceuticals
APLS
-12,537
Closed -$315K
APTV icon
980
Aptiv
APTV
$12.1B
-344,753
Closed -$26.2M
ARCB icon
981
ArcBest
ARCB
$3.52B
-7,768
Closed -$576K
ARR
982
Armour Residential REIT
ARR
$2.03B
-36,620
Closed -$648K
ARW icon
983
Arrow Electronics
ARW
$10.5B
-41,165
Closed -$4.54M
EFOR
984
Everforth Inc
EFOR
$752M
-101,409
Closed -$4.88M
ATEC icon
985
Alphatec Holdings
ATEC
$1.27B
-615,420
Closed -$12.9M
CVSA
986
Covista Inc
CVSA
$3.91B
-8,156
Closed -$844K
AVT icon
987
Avnet
AVT
$7.37B
-9,383
Closed -$451K
BA icon
988
Boeing
BA
$161B
-78,156
Closed -$17M
BATRK icon
989
Atlanta Braves Holdings Series B
BATRK
$3.29B
-7,545
Closed -$298K
BBIO icon
990
BridgeBio Pharma
BBIO
$15.8B
-125,201
Closed -$9.58M
BFAM icon
991
Bright Horizons
BFAM
$4.08B
-15,737
Closed -$1.6M
BF.B icon
992
Brown-Forman Class B
BF.B
$12.1B
-132,164
Closed -$3.44M
BHVN icon
993
Biohaven
BHVN
$2.24B
-25,647
Closed -$290K
BIIB icon
994
Biogen
BIIB
$29.5B
-187,608
Closed -$33M
BKNG icon
995
Booking.com
BKNG
$139B
-215,050
Closed -$46.1M
BKU icon
996
Bankunited
BKU
$3.49B
-351,974
Closed -$15.7M
BLDR icon
997
Builders FirstSource
BLDR
$7.82B
-20,704
Closed -$2.13M
BRBR icon
998
BellRing Brands
BRBR
$1.41B
-521,324
Closed -$13.9M
BRK.B icon
999
Berkshire Hathaway Class B
BRK.B
$1.06T
-8,360
Closed -$4.2M
BRKR icon
1000
Bruker
BRKR
$8.55B
-685,927
Closed -$32.3M

Similar funds

Freestone Grove Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Freestone Grove Partners deployed $589M of net new capital in Q1 2026, opening 515 new positions and adding to 214 existing holdings. Its largest new stake was Citigroup: 1,180,436 shares worth $134M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $303M trimmed.

  • Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
  • Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
  • Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
  • Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
  • Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
  • Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
  • Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.